Swedish (OMX) Pharma Industry Analysis
UpdatedMay 19, 2024
DataAggregated Company Financials
Companies33
- 7D0.5%
- 3M14.3%
- 1Y62.1%
- YTDn/a
The Pharma industry is up 5.2% in the last week, with Camurus up 6.0%. In the same time, Moberg Pharma was down 22%. This means that the industry has gained 65% over the past year. As for the next few years, earnings are expected to grow by 53% per annum.
Industry Valuation and Performance
Has the Swedish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 20 May 2024 | kr53.4b | kr6.4b | -kr766,339,926.75 | 71.8x | -69.7x | 8.4x |
| Wed, 17 Apr 2024 | kr49.4b | kr6.2b | -kr1,040,636,941.51 | 75.6x | -47.5x | 7.9x |
| Fri, 15 Mar 2024 | kr50.7b | kr6.2b | -kr1,038,051,980.71 | 77.1x | -48.8x | 8.1x |
| Sun, 11 Feb 2024 | kr51.7b | kr6.0b | -kr906,523,947.19 | 66.4x | -57x | 8.6x |
| Tue, 09 Jan 2024 | kr69.3b | kr9.4b | -kr1,184,302,974.00 | 65.3x | -58.5x | 7.3x |
| Thu, 07 Dec 2023 | kr63.1b | kr9.5b | -kr1,209,390,321.00 | 57.2x | -52.2x | 6.7x |
| Sat, 04 Nov 2023 | kr53.9b | kr9.3b | -kr1,122,821,864.00 | 82.7x | -48x | 5.8x |
| Mon, 02 Oct 2023 | kr51.1b | kr9.2b | -kr1,177,247,599.00 | 122.3x | -43.4x | 5.6x |
| Wed, 30 Aug 2023 | kr50.9b | kr9.2b | -kr1,129,789,648.00 | 141.7x | -45x | 5.5x |
| Fri, 28 Jul 2023 | kr51.1b | kr8.8b | -kr1,370,087,011.00 | 71.8x | -37.3x | 5.8x |
| Sun, 25 Jun 2023 | kr48.4b | kr8.4b | -kr1,693,005,057.00 | 77x | -28.6x | 5.8x |
| Tue, 23 May 2023 | kr48.1b | kr8.4b | -kr1,693,488,615.00 | 82.6x | -28.4x | 5.8x |
| Thu, 20 Apr 2023 | kr45.7b | kr8.0b | -kr1,794,950,643.00 | 92.3x | -25.5x | 5.7x |
| Sat, 18 Mar 2023 | kr45.5b | kr8.0b | -kr1,793,487,114.00 | 83.8x | -25.4x | 5.7x |
| Mon, 13 Feb 2023 | kr47.3b | kr7.3b | -kr1,954,882,124.00 | 276.3x | -24.2x | 6.5x |
| Wed, 11 Jan 2023 | kr48.4b | kr7.3b | -kr1,910,843,928.00 | 292.9x | -25.3x | 6.6x |
| Fri, 09 Dec 2022 | kr50.0b | kr7.3b | -kr1,874,961,206.00 | 299.7x | -26.7x | 6.9x |
| Sun, 06 Nov 2022 | kr49.6b | kr7.0b | -kr1,764,362,038.00 | 44x | -28.1x | 7.1x |
| Tue, 04 Oct 2022 | kr49.7b | kr7.0b | -kr1,739,483,570.00 | 48.4x | -28.6x | 7.1x |
| Thu, 01 Sep 2022 | kr51.9b | kr7.0b | -kr1,745,888,578.00 | 58.7x | -29.7x | 7.5x |
| Sat, 30 Jul 2022 | kr51.8b | kr6.9b | -kr1,552,569,830.00 | 42.1x | -33.4x | 7.5x |
| Mon, 27 Jun 2022 | kr51.7b | kr5.9b | -kr1,509,116,648.00 | 44.4x | -34.3x | 8.7x |
| Wed, 25 May 2022 | kr51.7b | kr5.7b | -kr1,489,338,766.00 | 46.2x | -34.7x | 9.1x |
| Fri, 22 Apr 2022 | kr54.7b | kr5.5b | -kr1,335,933,728.00 | 37.7x | -41x | 9.9x |
| Sun, 20 Mar 2022 | kr54.2b | kr5.4b | -kr1,389,013,613.00 | 37.9x | -39x | 10x |
| Tue, 15 Feb 2022 | kr50.3b | kr5.3b | -kr1,078,929,318.00 | 139.8x | -46.6x | 9.5x |
| Thu, 13 Jan 2022 | kr52.7b | kr5.5b | -kr1,099,873,199.00 | 122.1x | -47.9x | 9.7x |
| Sat, 11 Dec 2021 | kr55.6b | kr5.5b | -kr1,097,650,781.00 | 125.3x | -50.7x | 10.2x |
| Mon, 08 Nov 2021 | kr53.0b | kr5.0b | -kr1,425,360,451.00 | 127.6x | -37.2x | 10.5x |
| Wed, 06 Oct 2021 | kr54.1b | kr4.8b | -kr1,582,269,890.00 | 149x | -34.2x | 11.3x |
| Fri, 03 Sep 2021 | kr58.0b | kr4.8b | -kr1,413,242,854.26 | 159.3x | -41x | 12.1x |
| Sun, 01 Aug 2021 | kr55.4b | kr4.8b | -kr1,412,039,942.26 | 171.4x | -39.3x | 11.6x |
Price to Earnings Ratio
-36.2x
Current Industry PE
- Investors are relatively neutral on the Swedish Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 8.1x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Revenues for these companies have grown 12% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Comparison
How does Swedish Pharma compare with similar industries?
| SE Market | 0.39% | |
| Healthcare | 0.13% | |
| Pharma | 0.52% | |
| Pharma | 0.52% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CALTX Calliditas Therapeutics | kr117.20 | 5.8% +kr343.5m | 13.8% | PS5.2x | |
| IRLAB A IRLAB Therapeutics | kr15.25 | 16.9% +kr114.1m | 56.6% | PS139.3x | |
| SECARE Swedencare | kr55.05 | 0.9% +kr79.4m | 35.8% | PE122.2x | |
| ORX Orexo | kr21.15 | 9.8% +kr65.1m | 101.0% | PS1.2x | |
| IBT B Infant Bacterial Therapeutics | kr96.60 | 3.9% +kr48.5m | 122.6% | PS18860x |